SAN DIEGO--- Senomyx Announces Appointment of Donald Karanewsky, Ph.D., as Senior Vice President, Discovery
Senomyx, Inc. (NASDAQ:SNMX) , a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the packaged food and beverage industry, announced today the appointment of Donald S. Karanewsky, Ph.D., to the position of Senior Vice President, Discovery. Dr. Karanewsky's distinguished career includes leading successful chemistry discovery efforts at both large pharmaceutical companies and biotechnology research organizations.
Dr. Karanewsky received his Ph.D. in Chemistry from Harvard University and was granted a B.S. in Chemistry, Magna Cum Laude, from Stevens Institute of Technology in New Jersey. He has directed chemistry research teams and played senior management roles at a number of biotechnology institutions including Idun Pharmaceuticals, Ligand Pharmaceuticals and most recently, The Genomics Institute of the Novartis Research Foundation (GNF). In addition, he held principal positions at Glaxo Inc., Bristol-Myers Squibb, and the Squibb Institute for Medical Research. Dr. Karanewsky is an inventor on more than 70 issued US patents and has authored over 50 scientific publications.
"We are extremely fortunate to have someone of Don's caliber and experience joining Senomyx," said Mark J. Zoller, Ph.D., Executive Vice President of Discovery and Development and Chief Scientific Officer at the Company. "His areas of expertise include the generation of chemical libraries and the use of receptor-based assays for the identification and optimization of new compounds, which are important aspects of Senomyx's discovery efforts. Along with the recent addition of Albert Zlotnik, Ph.D., as Vice President, Biology, we have now filled our key scientific management positions. We look forward to having these highly regarded scientists direct our outstanding Biology and Discovery teams to further Senomyx's position as a leader in the science of human taste."
"Senomyx's scientific capabilities have been further validated with Nestle's initial commercialization of products containing new flavor ingredients that were discovered and developed in-house by Senomyx using our proprietary technologies," stated Kent Snyder, President and Chief Executive Officer of the Company. "This is an exciting time for Senomyx, and we welcome Don's input as we work to create new flavor ingredients that meet the needs of our seven world-class food and beverage company partners."
About Senomyx, Inc. (http://www.senomyx.com/)
Senomyx is a leading company using proprietary taste receptor-based assays, screening technologies and optimization chemistry to discover and develop novel flavors, flavor enhancers and taste modulators for the packaged food and beverage industry. The Company is focusing on the development of these flavor ingredients in the savory, sweet, salt and bitter areas. Senomyx has entered into product discovery and development collaborations with seven of the world's leading packaged food and beverage companies: Ajinomoto Co., Inc., Cadbury Schweppes, Campbell Soup Company, The Coca-Cola Company, Kraft Foods Global, Inc., Nestle SA, and Solae, LLC. Nestle is currently marketing products that contain one of Senomyx's flavor ingredients. For more information, please visit http://www.senomyx.com/.